(Q36434858)

14 August 2017

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease (English)

1 reference

multicenter clinical trial

14 August 2017

0 references

0 references

4

Alexander Drzezga

0 references

Stephen F Carter

Stephen F Carter

2

0 references

Anton Forsberg

Anton Forsberg

8

0 references

Rik Vandenberghe

Rik Vandenberghe

6

0 references

David J. Brooks

David J Brooks

5

0 references

Ove Almkvist

21

Ove Almkvist

1 reference

14 August 2017

9

Bengt Långström

1 reference

14 August 2017

1

Agneta Nordberg

1 reference

14 August 2017

22

Elke Kalbe

1 reference

14 August 2017

3

Juha Rinne

1 reference

14 August 2017

17

Koen Van Laere

1 reference

14 August 2017

24

Karl Herholz

1 reference

14 August 2017

Daniela Perani

7

1 reference

14 August 2017

Noora Scheinin

10

1 reference

14 August 2017

Mira Karrasch

11

1 reference

14 August 2017

Kjell Någren

12

1 reference

14 August 2017

Timo Grimmer

13

1 reference

14 August 2017

Isabelle Miederer

14

1 reference

14 August 2017

Paul Edison

15

1 reference

14 August 2017

Aren Okello

16

1 reference

14 August 2017

Natalie Nelissen

18

1 reference

14 August 2017

Mathieu Vandenbulcke

19

1 reference

14 August 2017

Valentina Garibotto

20

1 reference

14 August 2017

Rainer Hinz

23

1 reference

14 August 2017

8 September 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

14 August 2017

1 reference

14 August 2017

40

1 reference

14 August 2017

1

1 reference

14 August 2017

104-114

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-012-2237-2

14 August 2017

0 references

cites work

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Amyloid imaging and memory change for prediction of cognitive impairment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

The use of PET in Alzheimer disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Mild cognitive impairment: ten years later

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Mapping brain beta-amyloid

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Frequent amyloid deposition without significant cognitive impairment among the elderly

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Abeta amyloid deposition in the language system and how the brain responds

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Mild cognitive impairment as a diagnostic entity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

PET imaging of amyloid deposition in patients with mild cognitive impairment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Frequency of stages of Alzheimer-related lesions in different age categories

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Revising the definition of Alzheimer's disease: a new lexicon.

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

In vivo mapping of amyloid toxicity in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2237-2

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510420

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22961445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

FDA approves 18F-florbetapir PET agent

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22961445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22961445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-012-2237-2

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22961445

1 reference